All news from Dermatology
UT Southwestern researchers have made a major advance in uncovering the biology of how many thousands of disfiguring skin tumors occur in patients with a genetic disorder called neurofibromatosis type 1 (NF1).
This scientific advance could slow the development of these tumors. The study was published in the journal Cancer Discovery.
Phototherapy is a highly effective treatment for psoriasis, but it is one that is not entirely understood by young physicians. That’s a trend that should change for residents, according to some academic dermatology leaders.
When practiced in the right setting, said Abby Van Voorhees, M.D., a dermatologist for Eastern Virginia Medical School, phototherapy can significantly improve a patient’s psoriasis. But, for a variety of reasons, it’s not as common in regular practice today.
Topical treatment choices in psoriasis depend on the patient's need. For most patients with psoriasis , topical treatments play a considerable role in therapy. Nearly 80% of patients experience limited-to-moderate psoriasis disease, and topical therapies account for the majority, if not all, of their treatment. But, finding a treatment protocol that works with your lifestyle can be difficult.
Researchers conducted a cohort study involving 82,737 women in the Nurses' Health Study II to examine the correlation between the risk for incident rosacea and caffeine intake. Caffeine intake from coffee is inversely associated with the risk for incident rosacea. The study was published online in JAMA Dermatology.
Psoriasis is associated with increased risk of cardiovascular disease, but its effect on the course of cardiovascular disease remains unknown. The study show patients with hypertension and psoriasis more often required cardiovascular procedures and surgeries than hypertensive patients without psoriasis. The study was published in the Journal of Dermatology.
Tretinoin 0.05% lotion (ALTRENO Lotion) provides a statistically significant improvement in patients with moderate-to-severe acne, compared to placebo. The study was published in the October issue of the Journal of Drugs in Dermatology.
Massachusetts General Hospital (MGH) physicians are reporting an unexpected side-effect from treatment with dupilumab, which is FDA approved for the treatment of moderate to severe eczema, also called atopic dermatitis.
The study was published in JAMA Dermatology, the physicians describe how their 13-year-old patient, who has alopecia totalis, a total lack of scalp hair along with eczema, experienced significant hair regrowth while being treated with dupilumab, a drug marketed under the brand name Dupixent.
Atopic dermatitis, also known as eczema, is a skin condition that may affect people of all races and ethnicities but may occur more frequently in African-American children. According to US research, 19.3% of African-American children have eczema compared to 16.1% of European-American children.
There are many different treatment options available to consider when taking into account the unique characteristics of each patient. Here are some facts to help understand eczema.
A study examined that combination therapy with halobetasol propionate 0.01%/tazarotene 0.045% (HP/TAZ) lotion in patients with moderate to severe plaque psoriasis provides a sustained treatment effect after 8 weeks of therapy and a 4-week posttreatment period. The study was published in the Journal of Drugs in Dermatology.
Psoriasis is a long-lasting noncontagious skin condition that can cause much discomfort. Because of its unpleasing appearance, psoriasis is often accompanied by stigma. A new study reveals that myths surrounding the skin condition still persist in this era of readily available information.
Characterized by reddish, scaly lesions capable of causing itching, burning sensations, or both, psoriasis affects people's quality of life to a great degree. This and many other myths and ungrounded fears persist to this day in the United States so suggest a new study published in the Journal of the American Academy of Dermatology.
Research examining the common this stigma may be among the general population of the United States as well as among medical students. The study also found false perceptions about psoriasis continue to persist, including the belief that psoriasis is contagious and that it is not a serious illness.
The stigma associated with the autoimmune disease psoriasis may lead people to avoid patients who show signs of the condition, including not wanting to date, shake hands, or have people in their homes if they suffer from the disease. The study was published in the Journal of the American Academy of Dermatology
Researchers estimate that steps that have been taken towards the development of an acne vaccine. The investigators demonstrated for the first time that antibodies to a toxin secreted by bacteria in acne vulgaris can reduce inflammation in human acne lesions. The study was published in the Journal of Investigative Dermatology.